September 11, 2020 Comments Off on Patent delisted for Astrazeneca Ab drug BYDUREON PEN Posted in: Uncategorized
Annual Drug Patent Expirations for BYDUREON+PEN Bydureon Pen is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from one supplier. There are twenty-nine…
The post Patent delisted for Astrazeneca Ab drug BYDUREON PEN appear…
September 11, 2020 Comments Off on Patent delisted for Astrazeneca Ab drug BYDUREON Posted in: Uncategorized
Annual Drug Patent Expirations for BYDUREON Bydureon is a drug marketed by Astrazeneca Ab and is included in two NDAs. It is available from one supplier. There are thirty patents…
The post Patent delisted for Astrazeneca Ab drug BYDUREON appeared first…
